MAGGIE BOYKIN: Open Payments
NPI 1508327123 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,133 in 163 payments from 19 companies in 2025. Trend: 2023 $2,841 · 2024 $3,763 · 2025 $3,133
Food & beverage: $3,061Education: $72
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $473 |
| UCB, Inc. | 10 | $283 |
| Arcutis Biotherapeutics, Inc. | 6 | $235 |
| Regeneron Healthcare Solutions, Inc. | 10 | $213 |
| Lilly USA, LLC | 8 | $209 |
| Galderma Laboratories, L.P. | 16 | $201 |
| Amgen Inc. | 13 | $189 |
| Organon LLC | 7 | $174 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $156 |
| Janssen Biotech, Inc. | 12 | $152 |
Products named: DUPIXENT, Bimzelx, SKYRIZI, Zoryve, RINVOQ, OTEZLA, TREMFYA, CIBINQO.
Industry payments across SC — which companies pay providers there.
